GlassScriptPhysician profile
Nicholas Joseph Coretti
NPI 1235500422
$15,848.53
in general payments reported to CMS, 2019-2025
27 companies · $8,691 in 2025
The $8,691 reported for 2025 was more than what 95% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,649 · 2020: $638 · 2021: $298 · 2022: $488 · 2023: $846 · 2024: $1,239 · 2025: $8,691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $7,090 · Food and Beverage: $3,685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $7,090.00 |
| Food and Beverage | $3,685.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $7,155.00 | 2024-2025 | Restrata Wound Matrix |
| Stryker Corporation | $2,037.32 | 2019-2025 | Augment Injectable, Allowrap |
| Organogenesis INC. | $1,602.54 | 2020-2025 | Affinity, Puraply, Apligraf |
| Musculoskeletal Transplant Foundation INC. | $1,129.48 | 2019-2022 | |
| Smith+Nephew, INC. | $1,128.51 | 2022-2025 | Collagenase Santyl, Grafix Pl, Regranex |
| Aroa Biosurgery Incorporated | $455.02 | 2023-2025 | |
| Biotissue Holdings INC. | $320.10 | 2020-2025 | |
| Integra Lifesciences Corporation | $288.01 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Arthrex, INC. | $274.12 | 2020 | |
| Flower Orthopedics Coporation | $257.06 | 2019 | |
| Amniox Medical, INC. | $147.49 | 2019-2020 | |
| Medline Industries LP | $134.53 | 2019 | |
| Cardiovascular Systems INC. | $134.38 | 2020 | |
| Nevro Corp. | $120.82 | 2022 | |
| Boston Scientific Corporation | $108.97 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $100.91 | 2019-2023 | Krystexxa |
| Polynovo North America LLC | $93.62 | 2023-2025 | Novosorb Btm |
| Medela LLC | $75.05 | 2019 | |
| Paratek Pharmaceuticals, INC. | $63.91 | 2024-2025 | Nuzyra |
| Kci USA, INC. | $58.03 | 2021-2022 | |
| Innovation Technologies INC | $38.90 | 2023 | Irrisept |
| Misonix INC | $25.64 | 2020-2021 | |
| Averitas Pharma INC. | $22.46 | 2023 | Qutenza |
| Triad Life Sciences INC. | $21.28 | 2022 | |
| Embody, INC. | $19.68 | 2021 | |
| Medtronic, INC. | $18.33 | 2023 | Venaseal |
| Solventum Corporation | $17.37 | 2025 | Adaptic, Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Coretti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.